InvestorsHub Logo
Followers 113
Posts 25553
Boards Moderated 4
Alias Born 02/01/2004

Re: Trendliner post# 138154

Saturday, 03/10/2018 8:46:43 AM

Saturday, March 10, 2018 8:46:43 AM

Post# of 146210
Their tech is almost (not quite) identical.

It just makes sense, maybe, to cooperate/collaborate/integrate/save money.

To me anyway.

Otherwise let the courts decide the issue?

I'd like to see what Myers thinks.

Perhaps I am FOS???!

Background

The IBM nanomedicine polymer program - which started in IBM's Research labs four years ago with the mission to improve human health – stems from decades of materials development traditionally used for semiconductor technologies. This advance will expand the scope of IBM and the Institute of Bioengineering and Nanotechnology’s collaborative program, allowing scientists to simultaneously pursue multiple methods for creating materials to improve medicine and drug discovery. An industry and institute collaboration of this scale brings together the minds and resources of several leading scientific institutions to address the complex challenges in making practical nanomedicine solutions a reality.

The full research paper was published today in the peer-reviewed journal Advanced Functional Materials DOI: 10.1002/adfm.201301307.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News